MARKET

INO

INO

Inovio Pharmaceu
NASDAQ
1.840
-0.070
-3.66%
After Hours: 1.880 +0.04 +2.17% 17:31 02/06 EST
OPEN
1.910
PREV CLOSE
1.910
HIGH
1.920
LOW
1.830
VOLUME
4.36M
TURNOVER
0
52 WEEK HIGH
4.000
52 WEEK LOW
1.380
MARKET CAP
459.06M
P/E (TTM)
-1.2465
1D
5D
1M
3M
1Y
5Y
Inovio Pharma Releases Favorable Data From Booster DNA Vaccine Candidate For Ebola
Benzinga · 4d ago
BRIEF-Inovio Reports Positive Phase 1b Results For INO-4201 As Ebola Booster
Reuters · 4d ago
Inovio Pharmaceuticals Says INO-4201 Ebola Vaccine Booster Improved Humoral Response in Patients in Phase 1b Trial
Inovio Pharmaceuticals Says INO-4201 Ebola Vaccine Booster Improved Humoral Response in Patients in Phase 1b Trial
MT Newswires · 4d ago
INOVIO Announces Further Reorganization, Continues Focus on Promising DNA Candidates
Benzinga · 6d ago
Inovio in strategic reorganization; 11% headcount reduction
Seeking Alpha · 6d ago
BRIEF-INOVIO Announces Strategic Reorganization
Reuters · 6d ago
Inovio Pharmaceuticals to Slash 11% of Staff in Strategic Reorganization
Inovio Pharmaceuticals to Slash 11% of Staff in Strategic Reorganization
MT Newswires · 01/31 08:33
--Street Color: Inovio Pharmaceuticals to Slash Workforce by 11% as Part of Reorganization
--Street Color: Inovio Pharmaceuticals to Slash Workforce by 11% as Part of Reorganization
MT Newswires · 01/31 08:29
More
About INO
Inovio Pharmaceuticals, Inc. (INOVIO) is a biotechnology company. The Company is focused on bringing to market designed deoxyribonucleic acid (DNA) medicines and vaccines to help protect people from infectious diseases, including COVID-19, and to help treat people with cancer, and conditions associated with human papillomavirus (HPV). Its DNA medicines pipeline consists of three types of product candidates, namely prophylactic DNA vaccines, therapeutic DNA immunotherapies, and DNA encoded monoclonal and bispecific antibodies (dMAbs and dBTAs), which utilizes the two components of INOVIO's integrated platform, SynCon and CELLECTRA. The Company's SynCon technology creates optimized plasmids. INOVIO's CELLECTRA smart delivery devices facilitate uptake of its DNA medicines into the cell. Its SynCon DNA medicines are designed to generate antigen-specific antibody and T cell responses.

Webull offers kinds of Inovio Pharmaceuticals Inc stock information, including NASDAQ:INO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading INO stock methods without spending real money on the virtual paper trading platform.